Efficacy of liraglutide QD vs. sitagliptin QD vs. insulin glargine on liver fat when combined with metformin in T2DM subjects with NAFLD
Phase of Trial: Phase II
Latest Information Update: 07 Sep 2016
Price : $35 *
At a glance
- Drugs Liraglutide (Primary) ; Insulin glargine; Metformin; Sitagliptin
- Indications Non-alcoholic fatty liver disease; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 28 Aug 2016 Status changed from not yet recruiting to completed.
- 02 Jul 2014 New trial record
- 21 May 2014 Planned End Date changed from 1 Apr 2016 to 1 Mar 2016 as reported by Chinese Clinical Trial Register.